Antistofpatronen in een doorsnede van de Nederlandse bevolking. Onderzoek peilstations in 1980 en 1985
dc.contributor.author | Veer M van der | |
dc.contributor.author | Noorle Jansen LM van | |
dc.contributor.author | Nagel J | |
dc.contributor.author | Steenis G van | |
dc.contributor.author | Plantinga AD | |
dc.contributor.author | Rumke HC | |
dc.date.accessioned | 2012-12-12T15:07:34Z | |
dc.date.available | 2012-12-12T15:07:34Z | |
dc.date.issued | 1993-01-31 | |
dc.identifier | 927901007 | |
dc.identifier.uri | http://hdl.handle.net/10029/257133 | |
dc.description.abstract | Abstract niet beschikbaar | |
dc.description.abstract | An age-stratified investigation of antibody levels against diphtheria, tetanus, poliomyelitis, measles and rubella was carried out in 1980 and 1985. This selection of antigens was made because they are relevant to the Dutch National Immunization Programme. A nation-wide network of sentinel physicians collected 798 and 679 sera respectively in 1980 and in 1985 from healthy visitors of their office aged between 10 to 65 years and over. The 46 respectively 36 sentinel practices were distributed all over the country in such a way that the collected samples could be considered representative for the Dutch population. Generally, persons born after 1950-1955 are well protected against vaccination target diseases. With regard to tatanus, in all age groups older than 20 years, men are better protected than women. No difference in the sexes was found in the protective level of antibody against poliomyelitis. Vaccination against measles was included in the National Immunization programme in 1976. The participants of the present investigation are generally not vaccinated against measles. Thus, the study results were hardly influenced by these vaccinations. Everybody has antibodies against rubella with poor exceptions in the younger population. | |
dc.description.sponsorship | GHI Wijngaarden JK van | |
dc.format.extent | 63 p | |
dc.language.iso | nl | |
dc.relation.ispartof | RIVM Rapport 927901007 | |
dc.relation.url | http://www.rivm.nl/bibliotheek/rapporten/927901007.html | |
dc.subject | 02 | nl |
dc.subject | rijksvaccinatieprogramma | nl |
dc.subject | difterie | nl |
dc.subject | tetanus | nl |
dc.subject | poliomyelitis | nl |
dc.subject | antistofpatronen | nl |
dc.subject | vaccinaties | nl |
dc.subject | antibodies | en |
dc.subject | diphtheria | en |
dc.subject | tetanus | en |
dc.subject | poliomyelitis | en |
dc.subject | measles | en |
dc.subject | rubella | en |
dc.subject | population | en |
dc.subject | vaccination | en |
dc.title | Antistofpatronen in een doorsnede van de Nederlandse bevolking. Onderzoek peilstations in 1980 en 1985 | nl |
dc.title.alternative | [Antibody patterns in the Dutch population.] | en |
dc.type | Report | |
dc.date.updated | 2012-12-12T15:07:35Z | |
html.description.abstract | Abstract niet beschikbaar | |
html.description.abstract | An age-stratified investigation of antibody levels against diphtheria, tetanus, poliomyelitis, measles and rubella was carried out in 1980 and 1985. This selection of antigens was made because they are relevant to the Dutch National Immunization Programme. A nation-wide network of sentinel physicians collected 798 and 679 sera respectively in 1980 and in 1985 from healthy visitors of their office aged between 10 to 65 years and over. The 46 respectively 36 sentinel practices were distributed all over the country in such a way that the collected samples could be considered representative for the Dutch population. Generally, persons born after 1950-1955 are well protected against vaccination target diseases. With regard to tatanus, in all age groups older than 20 years, men are better protected than women. No difference in the sexes was found in the protective level of antibody against poliomyelitis. Vaccination against measles was included in the National Immunization programme in 1976. The participants of the present investigation are generally not vaccinated against measles. Thus, the study results were hardly influenced by these vaccinations. Everybody has antibodies against rubella with poor exceptions in the younger population. |